Xiaodoumiao and VBDdata Jointly Release '2017 Report on Pediatric Vaccines: The Children's Vaccine Market under Consumption Upgrade'

In recent years, with the rise in consumer spending levels and the upgrading of consumption patterns, expenditure on healthcare has increased significantly, and greater emphasis has been placed on prevention and health maintenance. Vaccination is the most effective measure for preventing and controlling infectious diseases, and it is also one of the most convenient, cost-effective, and safe public health interventions.

China’s national fiscal strength has gradually increased, and the immunization program system has been continuously supplemented and improved, with vaccines for a growing number of diseases now covered by the national immunization program. Meanwhile, the gradual implementation of the universal two-child policy has led to a significant annual increase in the number of newborns, which exceeded 17 million in 2016. In addition, changing consumer attitudes have driven a steady rise in demand for combination vaccines and self-paid vaccines, while the market launch of new vaccine products, such as the EV71 vaccine, has provided parents with more options. These factors have stimulated robust growth in the pediatric vaccine industry, creating greater market opportunities.

According to data from the medical research firm EvaluatePharma, the global vaccine market was valued at approximately $27.6 billion in 2015, with a compound annual growth rate (CAGR) of 5% from 2015 to 2022. The size of China’s pediatric vaccine market has exceeded RMB 10 billion, with a CAGR of over 8%, significantly surpassing the growth rate of the global vaccine market. It is projected that China’s pediatric vaccine market will reach RMB 15.6 billion by 2022.

As the pediatric vaccine market gradually becomes more active, VCBeat and the Xiaodoumiao APP jointly compiled the "Pediatric Vaccine Market in the Context of Consumption Upgrading—2017 Pediatric Vaccine Report." This report elaborates on the PEST factors influencing the pediatric vaccine market and the market status of the vaccine industry. It collected a total of 20,506 batch release data entries from January 2013 to October 2017, analyzing the pediatric vaccine market from dimensions such as vaccine production volume, varieties, and manufacturers.

Data analysis reveals that the competitiveness of domestic manufacturers in the pediatric vaccine sector is steadily strengthening. Imported products are scarce among Category I vaccines, while private enterprises hold the majority of the market share for Category II vaccines. Furthermore, the launch of novel vaccines has created additional consumption growth potential; for instance, the EV71 vaccine (inactivated Enterovirus 71 vaccine) gained strong market acceptance within just one year of its launch.

Individuals born in the 1980s and 1990s are a digitally native generation who primarily rely on the internet for information acquisition. This has spurred the emergence of an innovative sector focused on vaccination management apps, giving rise to products with tens of millions of users, such as Xiao Dou Miao, and fostering industry unicorns. The advent of vaccination apps has addressed numerous pain points in the vaccination process, significantly facilitating the integration of vaccination services with children’s health management.

Meanwhile, this report also selected Xiaodoumiao, the child vaccination app with the largest user base in China, to conduct a user sample survey. It investigated users’ consumption habits and studied the psychology of vaccine consumers. The report analyzes the demand upgrades and development potential of the pediatric vaccine market against the backdrop of consumption upgrading, thereby highlighting the changes taking place in China’s pediatric vaccine market.

Introduction to the Xiao Dou Miao App:

Xiaodoumiao is an essential parenting mobile app designed for parents of children aged 0–6, serving as China’s largest and most professional one-stop platform for infant vaccination services. With over 10 million users across 32 provinces and municipalities, and connections to more than 25,000 vaccination clinics, it has become the most widely used, extensively covered, frequently accessed, and parent-preferred vaccination application.

Xiao Dou Miao, by securing authorizations to interface with local databases and connect with vaccination sites, provides parents with scientific, intelligent, and personalized vaccination management services for their children throughout the entire immunization process. These services include electronic vaccination record inquiries, vaccination reminders, appointment scheduling, payment, and consultations. It is currently the only vaccine-related application capable of cross-regional operation and personalized adaptation to local immunization schedules.